Sharfuddin Chowdhury

Sharfuddin Chowdhury i

King Saud Medical City - Riyadh / Saudi Arabia
Others
AD Scientific Index ID: 4699097
person_outline Sharfuddin Chowdhury's MOST POPULAR ARTICLES
1-) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialO Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...The Lancet 397 (10285), 1637-1645, 2021599*2021
2-) Timing of surgery following SARS‐CoV‐2 infection: an international prospective cohort studyC Collaborative, GS Collaborative, S Chowdhury, et al.Anaesthesia 76 (6), 748-758, 2021592*2021
3-) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trialO Abani, A Abbas, F Abbas, M Abbas, S Abbasi, H Abbass, A Abbott, ...The Lancet 399 (10325), 665-676, 2022
4-) Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysisO Abani, A Abbas, F Abbas, J Abbas, K Abbas, M Abbas, S Abbasi, ...The Lancet 400 (10349), 359-368, 2022
5-) Transformation of health care and the new model of care in Saudi Arabia: Kingdom’s Vision 2030S Chowdhury, D Mok, L LeenenJournal of Medicine and Life 14 (3), 347, 2021